Nuwellis, Inc. (NUWE) stock
NUWENasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/3082% below fair value
$4.90−0.13 (-2.58%)
Close on Nov 13, 2026Market cap $2.65MP/E –Yield –
Nuwellis cash
Cash and short-term investments held at the end of each period.
Nuwellis's cash was $8.29M at Sep 30, 2026. For fiscal 2025 it was $1.09M, down 78.7% from the year before. Over ten years it grew -26.4% a year on average. The highest annual figure on record is $54.14M in fiscal 2013.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09M | -78.7% |
| FY2024 | Dec 31, 2024 | $5.10M | +34.1% |
| FY2023 | Dec 31, 2023 | $3.80M | -79.2% |
| FY2022 | Dec 31, 2022 | $18.31M | -24.4% |
| FY2021 | Dec 31, 2021 | $24.21M | +67.7% |
| FY2020 | Dec 31, 2020 | $14.44M | +1028.8% |
| FY2019 | Dec 31, 2019 | $1.28M | -76.7% |
| FY2018 | Dec 31, 2018 | $5.48M | -64.9% |
| FY2017 | Dec 31, 2017 | $15.60M | +1078.8% |
| FY2016 | Dec 31, 2016 | $1.32M | -94.3% |
| FY2015 | Dec 31, 2015 | $23.11M | -26.1% |
| FY2014 | Dec 31, 2014 | $31.29M | -42.2% |
| FY2013 | Dec 31, 2013 | $54.14M | +280.6% |
| FY2012 | Dec 31, 2012 | $14.22M | +116.7% |
| FY2011 | Dec 31, 2011 | $6.56M | -46.9% |
| FY2010 | Dec 31, 2010 | $12.35M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $8.29M | +167.9% |
| Q2 FY2026 | Jun 30, 2026 | $3.92M | -11.9% |
| Q1 FY2026 | Mar 31, 2026 | $2.08M | -18.5% |
| Q4 FY2025 | Dec 31, 2025 | $1.09M | -78.7% |
| Q3 FY2025 | Sep 30, 2025 | $3.09M | +62.2% |
| Q2 FY2025 | Jun 30, 2025 | $4.45M | +335.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.56M | +82.6% |
| Q4 FY2024 | Dec 31, 2024 | $5.10M | +34.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.91M | -61.3% |
| Q2 FY2024 | Jun 30, 2024 | $1.02M | -88.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.40M | -88.4% |
| Q4 FY2023 | Dec 31, 2023 | $3.80M | -79.2% |
| Q3 FY2023 | Sep 30, 2023 | $4.93M | -59.1% |
| Q2 FY2023 | Jun 30, 2023 | $8.90M | -42.0% |
| Q1 FY2023 | Mar 31, 2023 | $12.09M | -37.4% |
| Q4 FY2022 | Dec 31, 2022 | $18.31M | -24.4% |
| Q3 FY2022 | Sep 30, 2022 | $12.05M | -57.6% |
| Q2 FY2022 | Jun 30, 2022 | $15.35M | -36.0% |
| Q1 FY2022 | Mar 31, 2022 | $19.30M | -30.8% |
| Q4 FY2021 | Dec 31, 2021 | $24.21M | +67.7% |
| Q3 FY2021 | Sep 30, 2021 | $28.43M | +58.4% |
| Q2 FY2021 | Jun 30, 2021 | $23.98M | +206.6% |
| Q1 FY2021 | Mar 31, 2021 | $27.89M | +392.0% |
| Q4 FY2020 | Dec 31, 2020 | $14.44M | +1028.8% |
| Q3 FY2020 | Sep 30, 2020 | $17.95M | +393.9% |
| Q2 FY2020 | Jun 30, 2020 | $7.82M | +5.7% |
| Q1 FY2020 | Mar 31, 2020 | $5.67M | -50.7% |
| Q4 FY2019 | Dec 31, 2019 | $1.28M | -76.7% |
| Q3 FY2019 | Sep 30, 2019 | $3.63M | -55.8% |
| Q2 FY2019 | Jun 30, 2019 | $7.40M | +5.8% |
| Q1 FY2019 | Mar 31, 2019 | $11.49M | +9.4% |
| Q4 FY2018 | Dec 31, 2018 | $5.48M | -64.9% |
| Q3 FY2018 | Sep 30, 2018 | $8.22M | +227.2% |
| Q2 FY2018 | Jun 30, 2018 | $7.00M | +25.9% |
| Q1 FY2018 | Mar 31, 2018 | $10.50M | +532.4% |
| Q4 FY2017 | Dec 31, 2017 | $15.60M | +1078.8% |
| Q3 FY2017 | Sep 30, 2017 | $2.51M | – |
| Q2 FY2017 | Jun 30, 2017 | $5.56M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.66M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.32M | – |
See a number that looks wrong?